TFX logo

Teleflex Incorporated (TFX)

$126.88

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on TFX

Market cap

$5.61B

EPS

-7.29

P/E ratio

--

Price to sales

1.76

Dividend yield

1.072%

Beta

0.953134

Price on TFX

Previous close

$127.25

Today's open

$127.43

Day's range

$125.72 - $127.97

52 week range

$102.58 - $185.94

Profile about TFX

CEO

Liam J. Kelly

Employees

14100

Headquarters

Wayne, PA

Exchange

New York Stock Exchange

Shares outstanding

44194408

Issue type

Common Stock

TFX industries and sectors

Healthcare

Medical Equipment & Supplies

News on TFX

Teleflex: Selling, But How Much?

Teleflex Incorporated rebounded from lows after announcing a $2.03B divestiture of Acute Care, Interventional Urology, and OEM businesses. TFX will use $1B of net proceeds for share buybacks, reducing pro forma net debt to $1.5B, but revenue impact remains ambiguous. Shares now trade at 10x adjusted earnings, with market reaction positive despite uncertainty around divested revenue figures.

news source

Seeking Alpha • Dec 10, 2025

news preview

Teleflex to sell three of its businesses for $2.03 billion

Medical device maker Teleflex said on Tuesday it will sell three of its business units for a total of $2.03 billion in cash.

news source

Reuters • Dec 9, 2025

news preview

Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction

NEW YORK--(BUSINESS WIRE)--Montagu and Kohlberg, two leading middle-market private equity firms, today announced that they have entered into a definitive agreement to acquire Teleflex Medical OEM (the “Company”) from Teleflex Incorporated (NYSE: TFX) for $1.5 billion in a carve-out transaction. For over 40 years, Teleflex Medical OEM has developed and supplied custom-engineered interventional catheter components and sub-assemblies, as well as surgical fibers and sutures, used across fast-growin.

news source

Business Wire • Dec 9, 2025

news preview

Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion

Board of Directors authorizes new $1 billion share repurchase program Board of Directors authorizes new $1 billion share repurchase program

news source

GlobeNewsWire • Dec 9, 2025

news preview

Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript

Teleflex Incorporated ( TFX ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST Company Participants Liam Kelly - Chairman, President & CEO Conference Call Participants Matthew Taylor - Jefferies LLC, Research Division Presentation Matthew Taylor Jefferies LLC, Research Division Great. Thanks for joining us here for our next session.

news source

Seeking Alpha • Nov 18, 2025

news preview

Don't Overlook Teleflex (TFX) International Revenue Trends While Assessing the Stock

Explore Teleflex's (TFX) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

news source

Zacks Investment Research • Nov 17, 2025

news preview

Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript

Teleflex Incorporated ( TFX ) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business November 14, 2025 8:00 AM EST Company Participants Lawrence Keusch - Vice President of Investor Relations & Strategy Development Thierry Glauser Christopher Buller Liam Kelly - Chairman, President & CEO Conference Call Participants Kevin Croce Elliot Smith Patrick Wood - Morgan Stanley, Research Division Ravi Misra - Truist Securities, Inc., Research Division Larry Biegelsen - Wells Fargo Securities, LLC, Research Division Matthew O'Brien - Piper Sandler & Co., Research Division Shagun Singh Chadha - RBC Capital Markets, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to the Teleflex Vascular Intervention Investor Meeting. [Operator Instructions] Please note that this conference call is being recorded and will be available on the company's website for replay shortly.

news source

Seeking Alpha • Nov 14, 2025

news preview

Teleflex to Present at the Jefferies Global Healthcare Conference in London

WAYNE, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, at 10:00 a.m. (GMT).

news source

GlobeNewsWire • Nov 14, 2025

news preview

TFX Stock Falls Despite Q3 Earnings and Revenue Beat, '25 View Down

Teleflex posts strong Q3 earnings and revenue beats but trims 2025 outlook, sending shares slightly lower.

news source

Zacks Investment Research • Nov 13, 2025

news preview

These Analysts Cut Their Forecasts On Teleflex Following Q3 Results

Teleflex Incorporated (NYSE:TFX) reported better-than-expected earnings for the third quarter on Thursday.

news source

Benzinga • Nov 7, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Teleflex Incorporated

Open an M1 investment account to buy and sell Teleflex Incorporated commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in TFX on M1